Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Proteomics analysis of pancreatic cancer cell line (MiaPaCa-2)

ABSTRACT: Project describes the proteomics analysis using pSILAC approach to identify and quantify the hypoxia induced protein under serum and serum free conditions in pancreatic cancer cell line (MiaPaCa-2)

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture

DISEASE(S): Pancreatic Cancer

SUBMITTER: Nikhil Gupta

LAB HEAD: Newman Sze Siu Kwan

PROVIDER: PXD014087 | Pride | 2019-11-13

REPOSITORIES: pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	151229_Nikhil_SILAC_HxSF_01A.raw	Raw
	151229_Nikhil_SILAC_HxSF_01B.raw	Raw
	151229_Nikhil_SILAC_HxSF_02A.raw	Raw
	151229_Nikhil_SILAC_HxSF_02B.raw	Raw
	151229_Nikhil_SILAC_HxSF_03A.raw	Raw

Items per page:

1 - 5 of 242

Publications

ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer.

Gupta Nikhil N Park Jung Eun JE Tse Wilford W Low Jee Keem JK Kon Oi Lian OL McCarthy Neil N Sze Siu Kwan SK

Oncotarget 20191015 57

Pancreatic cancer is a leading cause of mortality worldwide due to the difficulty of detecting early-stage disease and our poor understanding of the mediators that drive progression of hypoxic solid tumors. We therefore used a heavy isotope 'pulse/trace' proteomic approach to determine how hypoxia (Hx) alters pancreatic tumor expression of proteins that confer treatment resistance, promote metastasis, and suppress host immunity. Using this method, we identified that hypoxia stress stimulates pan ...[more]

PMID: 31666928

Similar Datasets

MDAMB-231 Fusion Lumos, LC-MSMS

Project description:The protein phosphatase 2A (PP2A) heterotrimer PP2A-B56A is a human tumor suppressor. However, the molecular mechanisms inhibiting PP2A-B56A in cancer are poorly understood. Here, we report Phosphoproteomics study of single point mutation of CIP2A(K21A) in triple negative breast cancer cell line (MDA-MB-231).

2022-10-21 | PXD035179 | Pride

UMAD1 contributes to ESCRT-III dynamic subunit turnover during cytokinetic abscission

Project description:Abscission is the final stage of cytokinesis whereby the midbody, a thin intercellular bridge, is resolved to separate the daughter cells. Cytokinetic abscission is mediated by the Endosomal Sorting Complex Required for Transport (ESCRT), a conserved membrane remodelling machinery. The midbody organiser CEP55 recruits early acting ESCRT factors such as ESCRT-I and ALIX, which subsequently initiate the formation of ESCRT-III polymers that sever the midbody. We now identify UMAD1 as an ESCRT-I subunit that facilitates abscission. UMAD1 selectively associates with VPS37C and VPS37B, supporting the formation of cytokinesis-specific ESCRT-I assemblies. TSG101 recruits UMAD1 to the site of midbody abscission, to stabilise the CEP55/ESCRT-I interaction. We further demonstrate that the UMAD1/ESCRT-I interaction facilitates the final step of cytokinesis. Paradoxically, UMAD1 and ALIX co-depletion has synergistic effects on abscission whilst ESCRT-III recruitment to the midbody is not inhibited. Importantly, we find that both UMAD1 and ALIX are required for the dynamic exchange of ESCRT-III subunits at the midbody. Therefore, UMAD1 reveals a key functional connection between ESCRT-I and ESCRT-III that is required for cytokinesis.

2023-08-04 | PXD043940 | Pride

Diagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles

Project description:Alzheimer's Disease (AD) and Non-Demented Control (NDC) human sera were probed onto human protein microarrays in order to identify differentially expressed autoantibody biomarkers that could be used as diagnostic indicators. In the study presented here, 50 AD and 40 NDC human serum samples were probed onto human protein microarrays in order to identify differentially expressed autoantibodies. Microarray data was analyzed using several statistical significance algorithms, and autoantibodies that demonstrated significant group prevelance were selected as biomarkers of disease. Prediction classification analysis tested the diagnostic efficacy of the identified biomarkers; and differentiation of AD samples from other neurodegeneratively-diseased and non-neurodegeneratively-diseased controls (Parkinson's disease and breast cancer, respectively) confirmed their specificity.

2011-07-12 | E-GEOD-29676 | biostudies-arrayexpress

Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics

Project description:Ribosome profiling is a widespread tool for studying translational dynamics in human cells. Its central assumption is that ribosome footprint density on a transcript quantitatively reflects protein synthesis. Here, we test this assumption using pulsed-SILAC (pSILAC) high-accuracy targeted proteomics. We focus on multiple myeloma cells exposed to bortezomib, a first-line chemotherapy and proteasome inhibitor. In the absence of drug effects, we found that direct measurement of protein synthesis by pSILAC correlated well with indirect measurement of synthesis from ribosome footprint density. This correlation, however, broke down under bortezomib-induced stress. By developing a statistical model integrating longitudinal proteomic and mRNA-seq measurements, we found that proteomics could directly detect global alterations in translational rate caused by bortezomib; these changes are not detectable by ribosomal profiling alone. Further, by incorporating pSILAC data into a gene expression model, we predict cell-stress specific proteome remodeling events. These results demonstrate that pSILAC provides an important complement to ribosome profiling in measuring proteome dynamics. Timecourse experiment with six points over 48hr after bortezomib exposure in MM.1S myeloma cells. mRNA-seq and ribosome profiling data at each time point.

2017-05-18 | E-GEOD-69047 | biostudies-arrayexpress

Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles

Project description:Parkinson's Disease (PD) and Non-Demented Control (NDC) human sera were probed onto human protein microarrays in order to identify differentially expressed autoantibody biomarkers that could be used as diagnostic indicators. In the study presented here, 29 PD and 40 NDC human serum samples were probed onto human protein microarrays in order to identify differentially expressed autoantibodies. Microarray data was analyzed using several statistical significance algorithms, and autoantibodies that demonstrated significant group prevelance were selected as biomarkers of disease. Prediction classification analysis tested the diagnostic efficacy of the identified biomarkers; and differentiation of PD samples from other neurodegeneratively-diseased and non-neurodegeneratively-diseased controls (Alzheimer's disease, multiple sclerosis, and breast cancer) confirmed their specificity.

2012-02-27 | E-GEOD-29654 | biostudies-arrayexpress

Human aqueous humor of Primary open angle glaucoma LC-MS/MS

Project description:The main objective of this study was to adopt discovery based approach and define quantitative expression of human AH samples of glaucoma (N= 5) and non-glaucoma subjects (N=5) by using a state-of-the-art high performance liquid chromatography coupled mass spectrometry, to establish the relative regulation of AH proteome in glaucomatous eye and affected cellular pathways, and their correlation with disease pathogenesis

2018-06-15 | PXD007624 | Pride

Fibrinogen-like protein 1 is a novel biomarker for predicting disease activity and prognosis of rheumatoid arthritis

Project description:A total of 762 proteins were identified from 35 pooled rheumatoid arthritis (RA) patients with moderate to high disease activity and 60 pooled healthy serum samples. Among them, 142 proteins including 68 up-regulation and 74 down-regulation were identified in RA compared to healthy subjects.

2021-09-09 | PXD021689 | Pride

Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics

2017-05-18 | GSE69047 | GEO

Serum proteomics analysis in patients with endometriosis vs. controls

Project description:Serum proteomics analysis in patients with endometriosis vs. controls

2019-01-09 | PXD011091 | Pride

Mapping of phosphorylation target sites of obscurin-kin 1 within the cytoplasmic domain of N-cadherin by LC-MS/MS

Project description:To test our hypothesis that obscurin-kin1 modulates, at least in part, the mechanochemical coupling of cardiomyocytes via phosphorylation of N-cadherin, which has been shown to play a pivotal role in these processes, we set forth to identify the potential phosphorylation target sites of obscurin-kin1 within the cytoplasmic domain of N-cadherin. To this end, we used the baculovirus system to produce catalytically active kin1 coupled to 6xHis-tag (His-Kin1-CA) and the bacterial system to produce an N-cadherin construct containing a portion of the cytoplasmic domain (aa 786-880, accession no. P15116) tagged to 6xHis (His-Ncad786-880), which is enriched in Ser residues predicted to be potent phosphorylation target sites by EXPASY/GPS2.1. Following affinity purification of the recombinant proteins, His-Ncad786-880 was subjected to an in vitro kinase assay in the presence of His-Kin1-CA or control baculovirus preparation infected with empty vector that had undergone the same purification process as His-Kin1-CA. The reaction mixtures were subsequently subjected to liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis. An N-cadherin peptide encompassing amino acids 786-807 containing a single phosphorylation event at Ser-788 was repeatedly identified in the His-Ncad786-880 reaction mixture when treated with His-Kin1-CA, but not in the control preparation

2024-05-23 | PXD031003 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data